Prognostic effect of Ki-67 in common clinical subgroups of patients with HER2-negative, hormone receptor-positive early breast cancer

被引：0
|
作者：
Peter A. Fasching
Paul Gass
Lothar Häberle
Bernhard Volz
Alexander Hein
Carolin C. Hack
Michael P. Lux
Sebastian M. Jud
Arndt Hartmann
Matthias W. Beckmann
Dennis J. Slamon
Ramona Erber
机构：
[1] Friedrich Alexander University of Erlangen-Nuremberg,Department of Gynecology and Obstetrics, Comprehensive Cancer Center Erlangen
[2] University of California at Los Angeles,EMN, Erlangen University Hospital
[3] Friedrich Alexander University of Erlangen-Nuremberg,Division of Hematology/Oncology, Department of Medicine, David Geffen School of Medicine
[4] Friedrich Alexander University of Erlangen-Nuremberg,Biostatistics Unit, Department of Gynecology and Obstetrics, Comprehensive Cancer Center Erlangen
来源：
Breast Cancer Research and Treatment | 2019年 / 175卷
关键词：
Breast cancer; Ki-67; Proliferation; Molecular marker; Prognosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：617 / 625
页数：8
相关论文
共 50 条
  • [1] Prognostic effect of Ki-67 in common clinical subgroups of patients with HER2-negative, hormone receptor-positive early breast cancer
    Fasching, Peter A.
    Gass, Paul
    Haeberle, Lothar
    Volz, Bernhard
    Hein, Alexander
    Hack, Carolin C.
    Lux, Michael P.
    Jud, Sebastian M.
    Hartmann, Arndt
    Beckmann, Matthias W.
    Slamon, Dennis J.
    Erber, Ramona
    BREAST CANCER RESEARCH AND TREATMENT, 2019, 175 (03) : 617 - 625
  • [2] Prognostic impact of discrepant Ki67 and mitotic index on hormone receptor-positive, HER2-negative breast carcinoma
    L Rossi
    E Laas
    P Mallon
    A Vincent-Salomon
    J-M Guinebretiere
    F Lerebours
    R Rouzier
    J-Y Pierga
    F Reyal
    British Journal of Cancer, 2015, 113 : 996 - 1002
  • [3] Prognostic impact of discrepant Ki67 and mitotic index on hormone receptor-positive, HER2-negative breast carcinoma
    Rossi, L.
    Laas, E.
    Mallon, P.
    Vincent-Salomon, A.
    Guinebretiere, J-M
    Lerebours, F.
    Rouzier, R.
    Pierga, J-Y
    Reyal, F.
    BRITISH JOURNAL OF CANCER, 2015, 113 (07) : 996 - 1002
  • [4] Ki-67 evaluation at the hottest spot predicts clinical outcome of patients with hormone receptor-positive/HER2-negative breast cancer treated with adjuvant tamoxifen monotherapy
    Honma, Naoko
    Horii, Rie
    Iwase, Takuji
    Saji, Shigehira
    Younes, Mamoun
    Ito, Yoshinori
    Akiyama, Futoshi
    BREAST CANCER, 2015, 22 (01) : 71 - 78
  • [5] Ki-67 evaluation at the hottest spot predicts clinical outcome of patients with hormone receptor-positive/HER2-negative breast cancer treated with adjuvant tamoxifen monotherapy
    Naoko Honma
    Rie Horii
    Takuji Iwase
    Shigehira Saji
    Mamoun Younes
    Yoshinori Ito
    Futoshi Akiyama
    Breast Cancer, 2015, 22 : 71 - 78
  • [6] Clinical Validation of BCT Scores With Prognostic Factors in Hormone Receptor-positive, HER2-negative Early Breast Cancer
    Lee, Jeeyeon
    Kim, Won Hwa
    Jung, Jin Hyang
    Kim, Wan Wook
    Park, Chan Sub
    Lee, Ryu Kyung
    Park, Jee Young
    Chae, Yee Soo
    Lee, Soo Jung
    Kim, Hye Jung
    Park, Ji-Young
    Park, Ho Yong
    IN VIVO, 2019, 33 (06): : 2133 - 2139
  • [7] Management of hormone receptor-positive, HER2-negative early breast cancer
    Walsh, Elaine M.
    Smith, Karen L.
    Stearns, Vered
    SEMINARS IN ONCOLOGY, 2020, 47 (04) : 187 - 200
  • [8] EndoPredict® in early hormone receptor-positive, HER2-negative breast cancer
    K. Almstedt
    S. Mendoza
    M. Otto
    M. J. Battista
    J. Steetskamp
    A. S. Heimes
    S. Krajnak
    A. Poplawski
    A. Gerhold-Ay
    A. Hasenburg
    C. Denkert
    M. Schmidt
    Breast Cancer Research and Treatment, 2020, 182 : 137 - 146
  • [9] EndoPredict(R) in early hormone receptor-positive, HER2-negative breast cancer
    Almstedt, K.
    Mendoza, S.
    Otto, M.
    Battista, M. J.
    Steetskamp, J.
    Heimes, A. S.
    Krajnak, S.
    Poplawski, A.
    Gerhold-Ay, A.
    Hasenburg, A.
    Denkert, C.
    Schmidt, M.
    BREAST CANCER RESEARCH AND TREATMENT, 2020, 182 (01) : 137 - 146
  • [10] Prognostic significance of geminin expression levels in Ki67-high subset of estrogen receptor-positive and HER2-negative breast cancers
    Tomoko Yagi
    Natsuko Inoue
    Ayako Yanai
    Keiko Murase
    Michiko Imamura
    Yoshimasa Miyagawa
    Yukie Enomoto
    Arisa Nishimukai
    Yuichi Takatsuka
    Seiichi Hirota
    Kouhei Akazawa
    Yasuo Miyoshi
    Breast Cancer, 2016, 23 : 224 - 230
12345